One in 10 Democratic primary voters in NM chose ‘Uncommitted’ instead of Joe Biden

After nearly 13,000 people voted “Uncommitted” in New Mexico’s Democratic primary election, campaign organizers expressed gratitude for being able to feel empowered and in community with each other eight months into Israel’s war on Gaza. As a protest vote to convince President Joe Biden to stop supporting the war, as many as 12,852 registered Democrats […]

One in 10 Democratic primary voters in NM chose ‘Uncommitted’ instead of Joe Biden

After nearly 13,000 people voted “Uncommitted” in New Mexico’s Democratic primary election, campaign organizers expressed gratitude for being able to feel empowered and in community with each other eight months into Israel’s war on Gaza. As a protest vote to convince President Joe Biden to stop supporting the war, as many as 12,852 registered Democrats […]

One in 10 Democratic primary voters in NM chose ‘Uncommitted’ instead of Joe Biden

After nearly 13,000 people voted “Uncommitted” in New Mexico’s Democratic primary election, campaign organizers expressed gratitude for being able to feel empowered and in community with each other eight months into Israel’s war on Gaza. As a protest vote to convince President Joe Biden to stop supporting the war, as many as 12,852 registered Democrats […]

Alzheimer’s drug that can slow disease gets backing from FDA advisers

By MATTHEW PERRONE / ASSOCIATED PRESS A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with mild dementia caused by the brain-robbing disease. Food and Drug Administration advisers voted unanimously that the drug’s ability to slow the disease outweighs […]

Alzheimer’s drug that can slow disease gets backing from FDA advisers

By MATTHEW PERRONE / ASSOCIATED PRESS A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with mild dementia caused by the brain-robbing disease. Food and Drug Administration advisers voted unanimously that the drug’s ability to slow the disease outweighs […]

Alzheimer’s drug that can slow disease gets backing from FDA advisers

By MATTHEW PERRONE / ASSOCIATED PRESS A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with mild dementia caused by the brain-robbing disease. Food and Drug Administration advisers voted unanimously that the drug’s ability to slow the disease outweighs […]

WHAT TO EXPECT: Grants, childcare, contamination study on county commission agenda

At their regular meeting on Tuesday, Bernalillo County commissioners will consider taking steps to secure more than $23 million in state money that is intended for capital improvements and was approved by the New Mexico Legislature in the session earlier this year. Commissioners are asked to approve a resolution placing the money into the county’s […]

Who will be the next county manager?

Five people are in the running to become Bernalillo County’s next manager. County commissioners will meet in a closed session Tuesday afternoon to discuss how the finalists fared in interviews and then they will vote that evening during their regularly scheduled meeting to select the top three. The County Manager Search Committee selected Cindy Chavez, […]

What will become of The Epoch Times with its chief financial officer accused of money laundering?

By DAVID BAUDER / ASSOCIATED PRESS The arrest of an executive at The Epoch Times in a money-laundering scheme this week has drawn attention to a media outlet that has lived largely in the shadows since its founding in 2000 and a transformation during the Trump administration. Federal prosecutors in New York charged Weidong “Bill” Guan of […]

Alzheimer’s drug that can slow disease gets backing from FDA advisers

By MATTHEW PERRONE / ASSOCIATED PRESS A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with mild dementia caused by the brain-robbing disease. Food and Drug Administration advisers voted unanimously that the drug’s ability to slow the disease outweighs […]